The global uveitis treatment market size was valued at USD 2.23 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 9.1% from 2024 to 2030. The growth is due to rising prevalence of uveitis, increased awareness and early diagnosis. The growing R&D acti... Read More »
September 2024The global shingles vaccine market size was valued at USD 4.25 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 15.3% from 2024 to 2030. Market growth is expected to be driven by factors such as the heightened risk of shingles in individuals aged 60 and... Read More »
September 2024The U.S. PRP and stem cell alopecia treatment market size was valued at USD 212.7 million in 2023 and is anticipated to exhibit a CAGR of 5.4% from 2024 to 2030. This growth is attributed to the increasing number of people suffering from alopecia and rising awareness of novel treatment p... Read More »
September 2024The global HPV associated disorders market size was estimated at USD 17.6 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 4.9% from 2024 to 2030. The WHO highlights HPV as one of the most common sexually transmitted infections, leading to serious healt... Read More »
September 2024The global amyotrophic lateral sclerosis treatment market size was estimated at USD 667.3 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.8% from 2024 to 2030. The increasing incidence and prevalence of amyotrophic lateral sclerosis (ALS), particular... Read More »
September 2024The global liver health supplements market size was valued at USD 816.5 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.03% from 2024 to 2030. Consumers increasingly adopt preventive healthcare measures and pursue natural and herbal supplements to en... Read More »
September 2024The global women’s health therapeutics market size was valued at USD 43.1 billion in 2023 and is expected to expand at a CAGR of 4.0% from 2024 to 2030. The market growth is attributed to the increasing awareness of women's health issues, advancements in medical technology, and a g... Read More »
September 2024The global pregnancy care products market size was valued at USD 29.4 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 5.4% from 2024 to 2030. The rising awareness and emphasis on maternal health and the growing inclination of consumer preference for or... Read More »
September 2024The global age-related macular degeneration market size was valued at USD 10.82 billion in 2023 and is projected to grow at a CAGR of 8.2% from 2024 to 2030. The launch of new products, strong product pipeline, and increase in the prevalence rate of AMD are anticipated to be the major dr... Read More »
September 2024The global urothelial cancer drugs market size was valued at USD 3.24 billion in 2023 and is anticipated to grow at a CAGR of 11.1% from 2024 to 2030. This growth is driven by the rising prevalence of urothelial cancer, particularly bladder cancer. Innovations in cancer treatment, such a... Read More »
September 2024The Asia Pacific radiopharmaceuticals market size was valued at USD 1.91 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 10.5% from 2024 to 2030. The increasing prevalence of chronic diseases such as cancer and cardiovascular conditions has heightened ... Read More »
September 2024The global congestive heart failure drugs market size was valued at USD 7.69 billion in 2023 and is projected to grow at a CAGR of 14.6% from 2024 to 2030. The aging population with increased life expectancy, rising prevalence of heart failure and cardiovascular diseases, increasing R&am... Read More »
September 2024The global dry eye syndrome treatment market size was estimated at USD 5.92 billion in 2023 and is projected to grow at a CAGR of 7.97% from 2024 to 2030. The market is driven by the rising prevalence of DES due to factors such as aging and increased screen time, along with growing aware... Read More »
September 2024The Asia Pacific biopharma excipient market size was valued at USD 761.2 million in 2023 and is projected to grow at a CAGR of 5.8% from 2024 to 2030. This growth is attributed to the region's expanding pharmaceutical industry, advancements in functional excipients, and the rising use of... Read More »
September 2024The global CBD nutraceuticals market size was valued at USD 8.24 billion in 2023 and is projected to grow at a CAGR of 14.2% from 2024 to 2030. Some of the key growth driving factors for this industry are the increasing prevalence of chronic health disorders, growing consumer awareness r... Read More »
September 2024The Brazil sports nutrition market size was valued at USD 1.05 billion in 2023 and is projected to grow at a CAGR of 5.9% from 2024 to 2030. There is a growing prevalence of various lifestyle diseases such as diabetes, cardiovascular diseases, and obesity in Brazil. For instance, accordi... Read More »
September 2024The global artemisinin combination therapy market size was valued at USD 597.2 million in 2023 and is projected to grow at a CAGR of 8.2% from 2024 to 2030. It is attributed to the rising malaria in various regions. Malaria remains a significant public health challenge, with millions of ... Read More »
September 2024The global schizophrenia drugs market size was valued at USD 7.90 billion in 2023 and is projected to grow at a CAGR of 5.3% from 2024 to 2030. The increasing demand is due to the rising prevalence of schizophrenia and other related mental health disorders worldwide. This increase can be... Read More »
September 2024The global cold plasma market size was valued at USD 128.9 million in 2023 and is projected to grow at a CAGR of 15.8% from 2024 to 2030. This growth is attributed to the overall development of the healthcare industry, which has increased the demand for advanced technologies to enhance p... Read More »
September 2024The global cervical cancer treatment market size was valued at USD 8.16 billion in 2023 and is projected to grow at a CAGR of 5.4% from 2024 to 2030. This growth is attributed to advancements in oncology technology, increasing incidence of cervical cancer, recent advancements in imaging ... Read More »
September 2024